GBS Awarded $4 7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
New Brigham–Wyss Diagnostic Accelerator could enable fast creation of diagnostic technologies
Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Boston s Brigham and Women Hospital (Brigham) announce their newly founded Diagnostic Accelerator (Brigham-Wyss DxA). By combining the institutions broad clinical and multi-disciplinary bioengineering expertise, the Brigham-Wyss DxA will enable the fast creation of diagnostic technologies through deep collaborations in a process driven by previously unmet needs.
The Brigham-Wyss DxA presents a new type of research collaboration with the potential to significantly compress the timeframe for introducing new diagnostic technologies specifically developed to solve high-value clinical problems. The collaborators plan to achieve this through a formal process by which unmet diagnostic challenges are identified by the Brigham clinical community, effectively matched with highly appropriate technologies crea
GBS Awarded $4 7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
IQX Limited (NSX:IQX) Portfolio Company Awarded $6.3M Federal Govt Grant
Portfolio Company Awarded $6.3M Federal Govt GrantSydney, July 9, 2021 AEST (ABN Newswire) - iQX Limited (
NSX:IQX), on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), in which IQX holds 19% equity position, that LSBD s subsidiary GBS today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant to create a pilot Biosensor manufacturing facility. GBS Inc (
NASDAQ:GBS) is a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care. This project has been identified as one of six National Manufacturing Priorities identified by the Government under Modern Manufacturing Strategy (MMS).
Harvard s Wyss Institute and Brigham and Women s Hospital launch diagnostic accelerator eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.